Errors in Opioid Prescribing: A Prospective Survey in Cancer Pain

Journal of Pain and Symptom Management

Volumn 39, Issue 4, 2010, Pages 702-711

  Shaheen, Philip E ^a   LeGrand, Susan B ^a   Walsh, Declan ^a   Estfan, Bassam ^a   Davis, Mellar P ^a   Lagman, Ruth L ^a   Riaz, Mohammad ^a   Cheema, Bushra ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

cancer pain; Opioid prescribing errors; palliative medicine

Indexed keywords

FENTANYL; OPIATE; PETHIDINE;

ADULT; AGED; ARTICLE; CANCER PAIN; CANCER PATIENT; CONSULTATION; CONTINUOUS INFUSION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PRESCRIPTION; PROSPECTIVE STUDY; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; COMORBIDITY; FEMALE; HUMANS; MALE; MEDICATION ERRORS; MIDDLE AGED; NEOPLASMS; OHIO; PAIN; PRESCRIPTIONS; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TRETOQUINOL; YOUNG ADULT;

EID: 77950915479     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2009.09.009     Document Type: Article

References (27)

1. Ripamonti C., Zecca E., and De Conno F. Pharmacological treatment of cancer pain: alternative routes of opioid administration. Tumori 84 (1998) 289-300
2. Davis M., and Walsh D. Cancer pain syndromes. Eur J Palliat Care 7 (2000) 206-209
3. Smith H.S. Variations in opiod responsiveness. Pain Physician 11 (2008) 237-248
4. Davis M.P., and Walsh D. Epidemiology of cancer pain and factors influencing poor pain control. Am J Hosp Palliat Care 21 (2004) 137-142
5. Ventafridda V., Tamburini M., Caraceni A., De Conno F., and Naldi F. A validation study of the WHO method for cancer pain relief. Cancer 59 (1987) 850-856
6. Grond S., Zech D., Schug S.A., Lynch J., and Lehmann K.A. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage 6 (1991) 411-422
7. Walker V.A., Hoskin P.J., Hanks G.W., and White I.D. Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unit. J Pain Symptom Manage 3 (1988) 145-149
8. Kochhar R., LeGrand S.B., Walsh D., et al. Opioids in cancer pain: common dosing errors. Oncology (Williston Park) 17 (2003) 571-575
9. Walsh D., Rivera N., Davis M.P., Lagman R., and LeGrand S.B. Strategies for pain management: Cleveland clinic foundation guidelines for opioid dosing for cancer pain. Support Cancer Ther 1 (2004) 157-164
10. Strack P.L., Sherwood G.D., Adams-McNeill J., and Thomas E.J. Identifying and addressing medical errors in pain mismanagement. Jt Comm J Qual Improv 27 (2001) 191-199
11. Mercadante S. Predictive factors and opioid responsiveness in cancer pain. Eur J Cancer 34 (1998) 627-631
12. Von Roenn J.H., Cleeland C.S., Gonin R., Hatfield A.K., and Pandya K.J. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 119 (1993) 121-126
13. Cleeland C.S., Gonin R., Hatfield A.K., et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330 (1994) 592-596
14. Estfan B., Davis M.P., Walsh D., et al. The business of palliative medicine-part 5: service utilization in a comprehensive integrated program. Am J Hosp Palliat Med 24 (2007) 211-218
15. Sandblom G., Carlsson P., Sennfält K., and Varenhorst E. A population-based study of pain and quality of life during the year before death in men with prostate cancer. Br J Cancer 90 (2004) 1163-1168
16. Coyle N. In their own words: seven advanced cancer patients describe their experience with pain and the use of opioid drugs. J Pain Symptom Manage 27 (2004) 300-309
17. Ressel G.W. NIH releases statement on managing pain, depression, and fatigue in cancer. Am Fam Physician 67 (2003) 423-424
18. Hanks G.W., Cono F., Cherny N., et al., Expert Working Group of the Research Network of the European Association for Palliative Care. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84 (2001) 587-593
19. Krakowski I., Theobald S., Balp L., et al., FNCLCC. Summary version of the standards, opinions and recommendations for the use of analgesia for the treatment of nociceptive pain in adults with cancer (update 2002). Br J Cancer 89 Suppl 1 (2003) S67-S72
20. Benedetti C., Brock C., Cleeland C., et al., National Comprehensive Cancer Network. NCCN practice guidelines for cancer pain. Oncology (Williston Park) 4 (2000) 135-150
21. Pargeon K.L., and Hailey B.J. Barriers to effective cancer pain management: a review of the literature. J Pain Symptom Manage 18 (1999) 358-368
22. Walsh D., Donnelly S., and Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8 (2000) 175-179
23. Cherny N.J., Chang V., Frager G., et al. Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and route of administration. Cancer 76 (1995) 1283-1293
24. Mercadante S., Maddaloni S., Roccella S., and Salvaggio L. Predictive factors in advanced cancer pain treated only by analgesics. Pain 50 (1992) 151-155
25. Sanchez Gonzalez R., Ruperez Cordero O., Guerra Merino A., et al. Evaluation of primary care treatment of oncology patients with opiates. Aten Primaria 16 (1995) 92-95
26. Herndon C.M., Kalauokalani D.A., Cunningham A.J., Jackson II K.C., and Dunteman E.D. Anticipating and treating opioid-associated adverse effects. Expert Opin Drug Saf 2 (2003) 305-319
27. Hanks G.W., and Forbes K. Opioid responsiveness. Acta Anaesthesiol Scand 41 (1997) 154-158